Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Zomedica Corp (AMEX: ZOM) closed at $0.12 in the last session, down -1.97% from day before closing price of $0.13. In other words, the price has decreased by -$1.97 from its previous closing price. On the day, 3.53 million shares were traded. ZOM stock price reached its highest trading level at $0.1278 during the session, while it also had its lowest trading level at $0.1236.
Ratios:
We take a closer look at ZOM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.15 and its Current Ratio is at 10.82. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 08 ’24 when Blair Anthony K bought 150,000 shares for $0.12 per share. The transaction valued at 18,450 led to the insider holds 400,000 shares of the business.
POWERS JOHNNY D bought 100,000 shares of ZOM for $12,100 on Nov 11 ’24. The Director now owns 2,425,000 shares after completing the transaction at $0.12 per share. On Nov 11 ’24, another insider, HEATON LARRY C II, who serves as the CEO of the company, bought 100,000 shares for $0.12 each. As a result, the insider paid 12,200 and bolstered with 500,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 124453560 and an Enterprise Value of 42043876. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.56 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 1.612 whereas that against EBITDA is -1.43.
Stock Price History:
Over the past 52 weeks, ZOM has reached a high of $0.23, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -2.15%, while the 200-Day Moving Average is calculated to be -10.84%.
Shares Statistics:
According to the various share statistics, ZOM traded on average about 4.80M shares per day over the past 3-months and 4831360 shares per day over the past 10 days. A total of 979.95M shares are outstanding, with a floating share count of 962.66M. Insiders hold about 1.76% of the company’s shares, while institutions hold 8.27% stake in the company. Shares short for ZOM as of 1728950400 were 51140313 with a Short Ratio of 9.93, compared to 1726185600 on 43371169. Therefore, it implies a Short% of Shares Outstanding of 51140313 and a Short% of Float of 5.21.
